Evidence map›Paper›PMID 36013535›Full record

ArticleMedicina (Kaunas, Lithuania)2022

A Global Survey on Diagnostic, Therapeutic and Preventive Strategies in Intensive Care Unit-Acquired Weakness.

Felix Klawitter, Marie-Christine Oppitz, Nicolai Goettel, Mette M Berger, Carol Hodgson, Steffen Weber-Carstens, Stefan J Schaller, Johannes Ehler

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Felix KlawitterDepartment of Anesthesiology and Intensive Care Medicine, University Medical Center Rostock, 18057 Rostock, Germany.
Marie-Christine OppitzDepartment of Anesthesiology and Intensive Care Medicine, University Medical Center Rostock, 18057 Rostock, Germany.
Nicolai GoettelDepartment of Anesthesiology, University of Florida College of Medicine, Gainesville, FL 32610, USA.ORCID 0000-0003-0191-9775
Mette M BergerService of Adult Intensive Care, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland.ORCID 0000-0001-5427-1648
Carol HodgsonAustralian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia.
Steffen Weber-CarstensDepartment of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13357 Berlin, Germany.
Stefan J SchallerDepartment of Anesthesiology and Operative Intensive Care Medicine (CVK/CCM), Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.ORCID 0000-0002-6683-9584
Johannes EhlerDepartment of Anesthesiology and Intensive Care Medicine, University Medical Center Rostock, 18057 Rostock, Germany.ORCID 0000-0001-7866-9781
University of Rostock · DECharité - Universitätsmedizin Berlin · DEThe Alfred Hospital · AUTUM Klinikum · DEUniversity of Basel · CHUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Intensive care unit-acquired weakness (ICU-AW) is one of the most frequent neuromuscular complications in critically ill patients. We conducted a global survey to evaluate the current practices of diagnostics, treatment and prevention in patients with ICU-AW. Materials and Methods: A pre-survey was created with international experts. After revision, the final survey was endorsed by the European Society of Intensive Care Medicine (ESICM) using the online platform SurveyMonkey®. In 27 items, we addressed strategies of diagnostics, therapy and prevention. An invitation link was sent by email to all ESICM members. Furthermore, the survey was available on the ESICM homepage. Results: A total of 154 healthcare professionals from 39 countries participated in the survey. An ICU-AW screening protocol was used by 20% (28/140) of participants. Forty-four percent (62/141) of all participants reported performing routine screening for ICU-AW, using clinical examination as the method of choice (124/141, 87.9%). Almost 63% (84/134) of the participants reported using current treatment strategies for patients with ICU-AW. The use of treatment and prevention strategies differed between intensivists and non-intensivists regarding the reduction in sedatives (80.0% vs. 52.6%, p = 0.002), neuromuscular blocking agents (76.4% vs. 50%, p = 0.004), corticosteroids (69.1% vs. 37.2%, p < 0.001) and glycemic control regimes (50.9% vs. 23.1%, p = 0.002). Mobilization and physical activity are the most frequently reported treatment strategies for ICU-AW (111/134, 82.9%). The availability of physiotherapists (92/134, 68.7%) and the lack of knowledge about ICU-AW within the medical team (83/134, 61.9%) were the main obstacles to the implementation of the strategies. The necessity to develop guidelines for the screening, diagnosing, treatment and prevention of ICU-AW was recognized by 95% (127/133) of participants. Conclusions: A great heterogeneity regarding diagnostics, treatment and prevention of ICU-AW was reported internationally. Comprehensive guidelines with evidence-based recommendations for ICU-AW management are needed.

Indexed as

Intensive Care UnitsMuscle WeaknessCritical IllnessHumansRespiration, ArtificialSurveys and Questionnairescritical carecritical illness myopathycritical illness polyneuropathyneuromuscular diseasessurveys and questionnaires

Identifiers

PMID36013535
PMCPMC9416039
OpenAlexW4290720209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.